BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank7
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 3Y Ago
-0.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -20.56% |
| 2024 | 80.30% |
| 2023 | 101.95% |
| 2022 | 295.61% |
| 2021 | -13.46% |
| 2020 | -39.70% |
| 2019 | 58.89% |
| 2018 | 46.42% |
| 2017 | 123.05% |
| 2016 | 591.20% |